Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Alain Dagher

Clinical trials sponsored by Alain Dagher, explained in plain language.

Not yet recruiting 1

Obesity drug semaglutide tested for brain benefits in new trial

Disease control Not yet recruiting

This phase 4 trial will study 240 adults aged 35-55 with class I/II obesity to see if weight loss from semaglutide (Ozempic/Wegovy) improves brain health. Participants will take the drug weekly for 80 weeks and undergo MRI scans, cognitive tests, and blood work. The study also in…

Phase 4 • Sponsor: Alain Dagher • Aim: Disease control

Last updated Jun 28, 2026 00:00 UTC